Sutro Biopharma, Inc. (STRO)

Blueprint Medicines Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	64.03	190.3	69.27	47.25	30.41	206.15
Short-Term Investments	141.11	126.59	306.35	287.11	167.52	161.99
Cash & Short-Term Investments	205.13	316.9	375.62	334.36	197.94	368.14
Cash Growth	-51.85%	-15.63%	12.34%	68.92%	-46.23%	212.34%
Receivables	8	8.62	36.08	7.12	12.45	5.56
Prepaid Expenses	18.5	17.8	9.85	11.67	8.12	4.49
Total Current Assets	231.63	343.31	421.54	353.15	218.52	378.18
Property, Plant & Equipment	29.82	35.87	44.76	51.06	51.59	12.94
Long-Term Investments	-	-	-	-	68.78	-
Other Long-Term Assets	0.91	8.03	4.44	2.73	2.53	2.99
Total Assets	262.36	387.21	470.74	406.94	341.41	394.11
Accounts Payable	4.31	10.48	9.44	4.8	6.01	5.54
Accrued Expenses	49.92	40.13	34.1	24.83	17.07	8.82
Current Portion of Long-Term Debt	-	-	4.06	12.5	9.38	-
Current Portion of Leases	8.06	7.48	6.42	4.59	1.04	-
Current Income Taxes Payable	-	0.02	15.17	-	-	-
Current Unearned Revenue	11.96	69.78	20.67	16.76	5.5	14.6
Other Current Liabilities	-	4.01	3.9	3.08	2.75	0.63
Total Current Liabilities	74.25	131.89	93.75	66.55	41.74	29.6
Long-Term Debt	-	-	-	3.77	15.74	24.55
Long-Term Leases	11.54	15.67	23.15	29.57	31.22	-
Long-Term Unearned Revenue	206.99	193.35	202.49	89.89	-	6.1
Other Long-Term Liabilities	1.69	1.69	1.69	0.12	0.15	1.82
Total Liabilities	294.47	342.61	321.09	189.9	88.84	62.06
Common Stock	0.09	0.08	0.06	0.06	0.05	0.05
Additional Paid-In Capital	842.15	831.35	708.98	670.22	586.24	559.75
Retained Earnings	-874.34	-786.87	-559.41	-452.62	-333.41	-227.87
Comprehensive Income & Other	-0.01	0.04	0.02	-0.62	-0.31	0.13
Total Common Equity	-32.11	44.6	149.65	217.05	252.56	332.05
Shareholders' Equity	-32.11	44.6	149.65	217.05	252.56	332.05
Total Liabilities & Equity	262.36	387.21	470.74	406.94	341.41	394.11
Total Debt	19.59	23.15	33.64	50.43	57.37	24.55
Net Cash (Debt)	185.54	293.74	341.98	283.93	209.34	343.59
Net Cash Growth	-53.55%	-14.11%	20.45%	35.63%	-39.07%	177.99%
Net Cash Per Share	2.23	3.82	5.68	5.60	4.54	10.55
Filing Date Shares Outstanding	84.77	83.78	62.44	60.16	46.38	45.89
Total Common Shares Outstanding	84.72	82.53	61.01	57.5	46.33	45.75
Working Capital	157.38	211.42	327.8	286.61	176.78	348.59
Book Value Per Share	-0.38	0.54	2.45	3.77	5.45	7.26
Tangible Book Value	-32.11	44.6	149.65	217.05	252.56	332.05
Tangible Book Value Per Share	-0.38	0.54	2.45	3.77	5.45	7.26
Machinery	-	42.12	40	37.63	31.82	32.79
Construction In Progress	-	0.5	0.5	1.69	0.51	1.08
Leasehold Improvements	-	24.21	23.61	23.22	23.65	15.9

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q